What do systematic reviews say?

Sunitinib vs IMA901 + sunitinib (targeted agent versus tumour vaccine + targeted agent)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sorafenib vs sunitinib (targeted agent versus targeted agent)

The review found no eligible studies for this question.

• Targeted therapy for metastatic renal cell carcinoma 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Respite care vs polarity therapy

• Respite care for people with dementia and their carers 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 38 participants
  Very low

Yoga vs no therapy

• Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 675 participants
  Moderate

Yoga vs no therapy

• Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 146 participants
  Low

Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors

• Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 122 participants
  Very low

Continuous positive airway pressure (CPAP) vs no CPAP

• Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 57 participants
  Very low

Single component intervention vs control

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 212 participants
  Very low

Intermittent ICS vs placebo

• Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 143 participants
  Low

Intervention not reported

• Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis 2017 · Cochrane Headline outcomes only
  no estimate extracted
  31 participants
  Low

Topical antifungal vs placebo/no treatment

Topical antifungal may leads to lower heath‐related quality of life (HRQL) compared with placebo/no treatment (low certainty).

• Topical and systemic antifungal therapy for chronic rhinosinusitis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Systemic antifungal vs placebo/no treatment

• Topical and systemic antifungal therapy for chronic rhinosinusitis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Group 1 Pulmonary arterial hypertension ‐ PDE5i vs placebo, on combination therapy

• Phosphodiesterase 5 inhibitors for pulmonary hypertension 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 267 participants
  Moderate

Etretinate vs PUVA

The review found no eligible studies for this question.

• Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

CBT vs audiological care (tinnitus education and rehabilitation

• Cognitive behavioural therapy for tinnitus 2020 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 430 participants
  Moderate

CBT vs TRT (directive counselling and bilateral masking)

• Cognitive behavioural therapy for tinnitus 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 42 participants
  Low

Behavioural activation vs any comparator

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Low

Systemic antifungal vs placebo/no treatment

The review found no eligible studies for this question.

• Topical and systemic antifungal therapy for chronic rhinosinusitis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

BRIEF CBT vs STANDARD DURATION CBT

• Cognitive behavioural therapy (brief versus standard duration) for schizophrenia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Behavioural activation vs any comparator

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Low